Atlas Trials

Efficacy and Safety on Prouk for STEMI Patients in China

Clinical trial NCT02367976 · UNKNOWN

Trial details

NCT number
NCT02367976
Sponsor
Suzhou RxD Biopharmaceutical Co., Ltd
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
STEMI
Start date
2015-01-01
Primary completion
2016-12-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.